The line between the regulators and the regulated is murky, if it exists at all.
Emails obtained by a longstanding health journal reveal that the US Food and Drug Administration (FDA) advises departing employees to work “behind-the-scenes” while at Big Pharma to influence the supposed oversight agency.
Many oversight experts are surprised, but Congress isn’t.
